TIMLOZE

Class [005]
Pharmaceutical preparations for use in the treatment of bone diseases, connective tissue diseases, inflammatory diseases, namely, osteoarthritis, blood diseases and hormonal disorders, namely, polycystic ovary syndrome, hypogonadism, testosterone imbalance, androgen excess and estrogen deficiency; pharmaceutical preparations for use in the treatment of wasting and other muscle, fat and tissue loss caused by medical disorders or aging; pharmaceutical preparations for use in hormone replacement therapy; pharmaceutical preparations for use in the treatment of cardiovascular diseases, central and peripheral nervous system diseases, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy and Parkinson's disease, cancer, gynecological diseases, namely, post-menopausal bone loss, rheumatic diseases, genitourinary diseases, namely, urological diseases, gastroenterological diseases, infectious diseases, namely, urinary tract infections, eye infections and respiratory infections, dermatological diseases, namely, skin disorders, dermatitis, psoriasis and eczema, autoimmune diseases, blood diseases, genital diseases, namely, urological diseases, sexually transmitted diseases and inflammatory pelvic diseases, endocrine diseases, namely, growth and parathyroid-related disorders, intestinal diseases, internal medicine diseases, namely, respiratory diseases, pharmaceutical preparations for use in the treatment of alopecia; pharmaceutical preparations for use in the treatment of cognitive disorders and mood disorders; pharmaceutical preparations for use in the treatment of diabetes and insulin-related disorders and conditions; pharmaceutical preparations to treat wounds and trauma, namely, bone trauma, non-fragility bone fractures and healing of bone fractures